Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Zanger

Showing results (161-170 of 203) with videos related to

Pageof 21
Sort By:
International Journal of Molecular Sciences|January 5, 2021
Polycyclic Aromatic Hydrocarbons Activate the Aryl Hydrocarbon Receptor and the Constitutive Androstane Receptor to Regulate Xenobiotic Metabolism in Human Liver CellsLisa Goedtke, Heike Sprenger, Ute Hofmann, et al.
Gut|December 13, 2002
Safe treatment of thiopurine S-methyltransferase deficient Crohn's disease patients with azathioprineB A Kaskas, E Louis, U Hindorf, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 28, 2015
Comparative Analysis and Functional Characterization of HC-AFW1 Hepatocarcinoma Cells: Cytochrome P450 Expression and Induction by Nuclear Receptor AgonistsAlbert Braeuning, Maria Thomas, Ute Hofmann, et al.
Pharmacogenetics|October 3, 2002
Expression polymorphism of the blood-brain barrier component P-glycoprotein (MDR1) in relation to Parkinson's diseaseTaku Furuno, Maria-Teresa Landi, Mauro Ceroni, et al.
Hepatology (Baltimore, Md.)|June 27, 2006
Interindividual variability of canalicular ATP-binding-cassette (ABC)-transporter expression in human liverYvonne Meier, Christiane Pauli-Magnus, Ulrich M Zanger, et al.
Journal of Proteome Research|October 3, 2008
Distinction between human cytochrome P450 (CYP) isoforms and identification of new phosphorylation sites by mass spectrometryGorden Redlich, Ulrich M Zanger, Stephan Riedmaier, et al.
Nature|February 4, 1988
Characterization of the common genetic defect in humans deficient in debrisoquine metabolismF J Gonzalez, R C Skoda, S Kimura, et al.
British Journal of Clinical Pharmacology|September 5, 2002
The influence of CYP2B6, CYP2C9 and CYP2D6 genotypes on the formation of the potent antioestrogen Z-4-hydroxy-tamoxifen in human liverJanet K Coller, Niels Krebsfaenger, Kathrin Klein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 27, 2008
Role of genetic and nongenetic factors for fluorouracil treatment-related severe toxicity: a prospective clinical trial by the German 5-FU Toxicity Study GroupMatthias Schwab, Ulrich M Zanger, Claudia Marx, et al.
British Journal of Pharmacology|August 3, 2024
In silico and biological analyses of missense variants of the human biliary efflux transporter ABCC2: effects of novel rare missense variantsCharlotte Kölz, Fabienne Z Gaugaz, Niklas Handin, et al.
Pageof 21

Showing results (161-170 of 203) with videos related to

Sort By:
Pageof 21
International Journal of Molecular Sciences|January 5, 2021
Polycyclic Aromatic Hydrocarbons Activate the Aryl Hydrocarbon Receptor and the Constitutive Androstane Receptor to Regulate Xenobiotic Metabolism in Human Liver CellsLisa Goedtke, Heike Sprenger, Ute Hofmann, et al.
Gut|December 13, 2002
Safe treatment of thiopurine S-methyltransferase deficient Crohn's disease patients with azathioprineB A Kaskas, E Louis, U Hindorf, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 28, 2015
Comparative Analysis and Functional Characterization of HC-AFW1 Hepatocarcinoma Cells: Cytochrome P450 Expression and Induction by Nuclear Receptor AgonistsAlbert Braeuning, Maria Thomas, Ute Hofmann, et al.
Pharmacogenetics|October 3, 2002
Expression polymorphism of the blood-brain barrier component P-glycoprotein (MDR1) in relation to Parkinson's diseaseTaku Furuno, Maria-Teresa Landi, Mauro Ceroni, et al.
Hepatology (Baltimore, Md.)|June 27, 2006
Interindividual variability of canalicular ATP-binding-cassette (ABC)-transporter expression in human liverYvonne Meier, Christiane Pauli-Magnus, Ulrich M Zanger, et al.
Journal of Proteome Research|October 3, 2008
Distinction between human cytochrome P450 (CYP) isoforms and identification of new phosphorylation sites by mass spectrometryGorden Redlich, Ulrich M Zanger, Stephan Riedmaier, et al.
Nature|February 4, 1988
Characterization of the common genetic defect in humans deficient in debrisoquine metabolismF J Gonzalez, R C Skoda, S Kimura, et al.
British Journal of Clinical Pharmacology|September 5, 2002
The influence of CYP2B6, CYP2C9 and CYP2D6 genotypes on the formation of the potent antioestrogen Z-4-hydroxy-tamoxifen in human liverJanet K Coller, Niels Krebsfaenger, Kathrin Klein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 27, 2008
Role of genetic and nongenetic factors for fluorouracil treatment-related severe toxicity: a prospective clinical trial by the German 5-FU Toxicity Study GroupMatthias Schwab, Ulrich M Zanger, Claudia Marx, et al.
British Journal of Pharmacology|August 3, 2024
In silico and biological analyses of missense variants of the human biliary efflux transporter ABCC2: effects of novel rare missense variantsCharlotte Kölz, Fabienne Z Gaugaz, Niklas Handin, et al.
Pageof 21